KristenKellyPierceMD
Infectious Disease • Burlington, VTAssistant Professor, Medicine, University of Vermont College of Medicine
Dr. Pierce is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Avenue
Fletcher Allen Health Care
Burlington, VT 05401Phone+1 802-847-2700
Education & Training
University of Vermont Medical CenterFellowship, Infectious Disease, 2006 - 2008- University of Vermont Medical CenterResidency, Internal Medicine, 2003 - 2006
University of Vermont College of MedicineClass of 2003
Certifications & Licensure
NY State Medical License 2024 - 2026
VT State Medical License 2008 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- Localized Inflammation in Dengue Vaccine-Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome.Camilla Strother, Nicole Bouffard, Olha Smolynets, Nancy R Graham, Evan A Elko
The Journal of Investigative Dermatology. 2024-12-27 - 12 citationsSafety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial.Mary-Claire R Walsh, Mohammed Shafiul Alam, Kristen K Pierce, Marya Carmolli, Masud Alam
The Lancet. Infectious Diseases. 2024-02-01 - 6 citationsTV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies.Kristen K Pierce, Anna P Durbin, Mary-Claire R Walsh, Marya Carmolli, Beulah P Sabundayo
The Journal of Clinical Investigation. 2024-02-01
Press Mentions
- UVM Medical Center Completes COVID-19 Vaccine Study EnrollmentJanuary 10th, 2021
- University of Vermont Medical Center Ramps up Phase 3 Trial Investigating AZD1222 COVID-19 Vaccine Candidate: Seeking VolunteersOctober 29th, 2020
NIH Begins Clinical Trial of Live, Attenuated Zika VaccineAugust 22nd, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
